O1 - Is semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting in the phase II hypo-FLAME 2.0 trial associated with acceptable acute toxicity?
We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.